+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Heart Defect Closure Devices Market 2019-2023 - Product Image

Global Heart Defect Closure Devices Market 2019-2023

  • ID: 4752653
  • Report
  • Region: Global
  • 137 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott
  • AtriCure Inc.
  • Cardia Inc.
  • Lifetech Scientific
  • MORE
AF is the most commonly encountered arrhythmia in clinical practice. It is associated with increased morbidity, especially stroke and heart failure, and mortality. AF is becoming a major public health burden across the world, and its prevalence is expected to increase due to the rapidly growing geriatric population, especially in developing countries. Other risk factors of AF such as high blood pressure (BP), obesity, diabetes, heart failure, ischemic heart disease, chronic kidney disease (CKD), and the heavy consumption of alcohol are also on the rise. Hence, the rising prevalence of AF will increase the demand for LAA closure therapy. which will drive the growth of the global heart defect closure devices market. Analysts have predicted that the heart defect closure devices market will register CAGR of over 29% by 2023.

Market Overview

Technological advances in heart defect closure

There had been several significant technological advances in all forms of cardiovascular care. especially in the treatment of structural heart disease, in the last decade. The advances in catheterization techniques, medical imaging, and devices have increased the adoption of minimally invasive procedures. Therefore, interventional cardiology procedures have now become the standard of care to treat ASD and PFO.

Shortage of skilled surgeons to perform heart defect closure procedures

There is a global shortage of cardiologists, including general cardiologists, electrophysiologists: interventional cardiologists, both coronary and peripheral, and pediatric cardiologists. This shortage is attributed to the aging cardiology community, limited growth in fellowship positions, increasing burden of cardiovascular diseases (CVDs): and evolving health care reforms.

For the detailed list of factors that will drive and challenge the growth of the heart defect closure devices market during the 2019-2023, view the full report.

Competitive Landscape

The market appears to be moderately concentrated and with the presence of few vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • AtriCure Inc.
  • Cardia Inc.
  • Lifetech Scientific
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • LAA closure devices - Market size and forecast 2018-2023
  • PFO closure devices - Market size and forecast 2018-2023
  • ASD closure devices - Market size and forecast 2018-2023
  • Other heart defect closure devices - Market size and forecast 2018-2023
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • Europe - Market size and forecast 2018-2023
  • North America - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 10: MARKET TRENDS
  • Increasing number of clinical trials to expand geographic coverage of heart defect closure devices
  • Rising focus on R&D of bioabsorbable occluders
  • Use of 3D imaging in heart defect closure procedures
PART 11: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 12: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Cardia, Inc.
  • Lifetech Scientific
  • W. L. Gore & Associates, Inc.
PART 13: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits:
Exhibit 01: Years in consideration
Exhibit 02: Global medical devices market
Exhibit 03: Segments of global medical devices market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: LAA closure devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: LAA closure devices - Year-over-year growth 2019-2023 (%)
Exhibit 22: PFO closure devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: PFO closure devices - Year-over-year growth 2019-2023 (%)
Exhibit 24: ASD closure devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: ASD closure devices - Year-over-year growth 2019-2023 (%)
Exhibit 26: Other heart defect closure devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 27: Other heart defect closure devices - Year-over-year growth 2019-2023 (%)
Exhibit 28: Market opportunity by product
Exhibit 29: Customer landscape
Exhibit 30: Market share by geography 2018-2023 (%)
Exhibit 31: Geographic comparison
Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 34: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: North America - Year-over-year growth 2019-2023 (%)
Exhibit 36: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 38: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 39: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 40: Key leading countries
Exhibit 42: Market opportunity
Exhibit 43: Decision framework
Exhibit 44: Impact of drivers and challenges
Exhibit 45: Vendor landscape
Exhibit 46: Landscape disruption
Exhibit 47: Vendors covered
Exhibit 48: Vendor classification
Exhibit 49: Market positioning of vendors
Exhibit 50: Abbott - Vendor overview
Exhibit 51: Abbott - Business segments
Exhibit 52: Abbott - Organizational developments
Exhibit 53: Abbott - Geographic focus
Exhibit 54: Abbott - Segment focus
Exhibit 55: Abbott - Key offerings
Exhibit 56: Abbott - Key customers
Exhibit 57: AtriCure, Inc. - Vendor overview
Exhibit 58: AtriCure, Inc. - Product segments
Exhibit 59: AtriCure, Inc. - Organizational developments
Exhibit 60: AtriCure, Inc. - Geographic focus
Exhibit 61: AtriCure, Inc. - Segment focus
Exhibit 62: AtriCure, Inc. - Key offerings
Exhibit 63: AtriCure, Inc. - Key customers
Exhibit 64: Boston Scientific Corporation - Vendor overview
Exhibit 65: Boston Scientific Corporation - Business segments
Exhibit 66: Boston Scientific Corporation - Organizational developments
Exhibit 67: Boston Scientific Corporation - Geographic focus
Exhibit 68: Boston Scientific Corporation - Segment focus
Exhibit 69: Boston Scientific Corporation - Key offerings
Exhibit 70: Boston Scientific Corporation - Key customers
Exhibit 71: Cardia, Inc. - Vendor overview
Exhibit 72: Cardia, Inc. - Product segments
Exhibit 73: Cardia, Inc. - Key offerings
Exhibit 74: Cardia, Inc. - Key customers
Exhibit 75: Lifetech Scientific - Vendor overview
Exhibit 76: Lifetech Scientific - Business segments
Exhibit 77: Lifetech Scientific - Organizational developments
Exhibit 78: Lifetech Scientific - Geographic focus
Exhibit 79: Lifetech Scientific - Segment focus
Exhibit 80: Lifetech Scientific - Key offerings
Exhibit 81: Lifetech Scientific - Key customers
Exhibit 82: W. L. Gore & Associates, Inc. - Vendor overview
Exhibit 83: W. L. Gore & Associates, Inc. - Product segments
Exhibit 84: W. L. Gore & Associates, Inc. - Organizational developments
Exhibit 85: W. L. Gore & Associates, Inc. - Key offerings
Exhibit 86: W. L. Gore & Associates, Inc. - Key customers
Exhibit 87: Validation techniques employed for market sizing
Exhibit 88: List of abbreviations
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • AtriCure Inc.
  • Cardia Inc.
  • Lifetech Scientific
  • MORE
Global Heart Defect Closure Devices Market 2019-2023

The publisher recognizes the following companies as the key players in the global heart defect closure devices market: Abbott, AtriCure, Inc., Boston Scientific Corporation, Cardia, Inc., Lifetech Scientific, W. L. Gore & Associates, Inc.

Commenting on the report, an analyst from the publishing team said: “The latest trend gaining momentum in the market is the increasing number of clinical trials to expand geographic coverage of heart defect closure devices.”

According to the report, one of the major drivers for this market is the demand for heart defect closure devices is increasing, which is driving the growth of the market.

Further, the report states that one of the major factors hindering the growth of this market is the limitations and complications associated with the heart defect closure devices.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott
  • AtriCure Inc.
  • Boston Scientific Corporation
  • Cardia Inc.
  • Lifetech Scientific
  • W. L. Gore & Associates Inc.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4752653
Adroll
adroll